Drop in Proportion of Neonates With Long IV Therapy for UTI

Decrease from 50 percent in 2005 to 19 percent in 2015; not linked to increase in hospital readmissions
feeding infant
feeding infant

FRIDAY, Nov. 3, 2017 (HealthDay News) -- From 2005 to 2015 there was a decrease in the proportion of infants aged ≤60 days with a urinary tract infection (UTI) who received four or more days of intravenous (IV) antibiotics, according to a study published online Nov. 2 in Pediatrics.

William W. Lewis-de los Angeles, M.D., from Ann & Robert H. Lurie Children's Hospital of Chicago, and colleagues analyzed data from the Pediatric Health Information System database from 2005 through 2015 for infants aged ≤60 days old diagnosed with a UTI who were admitted to a children's hospital and received IV antibiotics.

The researchers found that from 2005 to 2015 there was a decrease in the proportion of infants ≤60 days old receiving four or more days of IV antibiotics (long IV treatment) from 50 to 19 percent. There was variation in the proportion of infants aged ≤60 days receiving long IV treatment at 46 children's hospitals from 3 to 59 percent; this was not associated with readmission (correlation coefficient, 0.13; P = 0.37). Readmission for a UTI was associated with younger age and female sex in multivariable analysis but not with duration of IV antibiotic therapy (adjusted odds ratio for long IV treatment, 0.93; 95 percent confidence interval, 0.52 to 1.67)

"These findings support the safety of short-course IV antibiotic therapy for appropriately selected neonates," the authors write.

One author disclosed ties to Merck.

Abstract
Full Text (subscription or payment may be required)

Related Stories

No stories found.
logo
www.healthday.com